- Report
- April 2026
- 92 Pages
Europe
From €5375EUR$5,995USD£4,593GBP
- Report
- April 2026
- 93 Pages
Asia Pacific
From €5375EUR$5,995USD£4,593GBP
- Report
- April 2026
- 75 Pages
North America
From €5375EUR$5,995USD£4,593GBP
- Report
- February 2026
- 39 Pages
United States
From €4479EUR$4,995USD£3,827GBP
- Report
- February 2026
- 117 Pages
Europe
From €5375EUR$5,995USD£4,593GBP
- Report
- February 2026
- 109 Pages
North America
From €5375EUR$5,995USD£4,593GBP
- Report
- February 2026
- 117 Pages
Asia Pacific
From €5375EUR$5,995USD£4,593GBP
- Report
- January 2026
- 90 Pages
Asia Pacific
From €3542EUR$3,950USD£3,026GBP
- Report
- January 2026
- 94 Pages
Europe
From €3542EUR$3,950USD£3,026GBP
- Report
- January 2026
- 84 Pages
North America
From €3093EUR$3,450USD£2,643GBP
- Report
- January 2026
- 76 Pages
Middle East, Africa
From €3093EUR$3,450USD£2,643GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4035EUR$4,500USD£3,447GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4035EUR$4,500USD£3,447GBP
- Report
- October 2025
- 85 Pages
Middle East
From €4035EUR$4,500USD£3,447GBP
From €4035EUR$4,500USD£3,447GBP
- Report
- October 2025
- 87 Pages
United States
From €4035EUR$4,500USD£3,447GBP
- Report
- July 2024
- 288 Pages
Global
From €5269EUR$6,083USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5269EUR$6,083USD£4,350GBP
- Report
- September 2024
- 593 Pages
Global
From €4303EUR$4,799USD£3,677GBP
- Report
- January 2025
- 867 Pages
Global
From €4303EUR$4,799USD£3,677GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more